A 12-week Double-blind, Randomized, Multi-center Study Comparing the Efficacy and Safety of Once Monthly Subcutaneous AMG 334 Against Placebo in Adult Episodic Migraine Patients (EMPOwER)
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This study is to evaluate the efficacy and safety of AMG334 in adult patients with episodic migraine
Fields of Study & Subjects
Migraine and Headache Studies
Pain Mechanisms and Treatments
Intracranial Aneurysms: Treatment and Complications
Publication details
- Journal / source
- Vivli
- Publication date
- 27 March 2026
- Language
- EN
- Document type
- Dataset